Rhizoma Amorphophalli inhibits TNBC cell proliferation, migration, invasion and metastasis through the PI3K/Akt/mTOR pathway
Dados Bibliográficos
| ID | 14734682 |
|---|---|
| Autores | Chunyu Wu (0009-0006-8834-3359, Shanghai University of Traditional Chinese Medicine), Shengliang Qiu (0000-0002-4538-594X, Zhejiang Chinese Medical University), Pei Liu (0000-0001-5330-9640, Zhejiang Chinese Medical University), Yuqing Ge (0000-0001-8041-186X, Zhejiang Chinese Medical University), Xiufei Gao (0000-0002-3188-2216, Zhejiang Chinese Medical University, autor correspondente) |
| Ano | 2018 |
| Volume | 211 |
| Páginas | 89-100 |
| Data de publicação | 2018-01-01 |
| Peer Reviewed | Sim |
| Open Access | Sim |
| Tipo | ARTICLE |
| Periódico | Journal of Ethnopharmacology (JOURNAL) |
| Identificadores do periódico | ISSN: 0378-8741 • E-ISSN: 1872-7573 |
| Editora | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.jep.2017.09.033 |
| PMID | 28962890 |
| OpenAlex | W2757557727 |
| Idioma | EN |
| Citações recebidas | 5 |
| Referências citadas | 26 |
Biology · Cancer · Cell growth · Discovery and development of mTOR inhibitors · Metastasis · PI3K/AKT/mTOR pathway · Protein kinase B · Signal transduction · Chromatography in Natural Products · Flavonoids in Medical Research · Medicine · Phytochemical Studies and Bioactivities · Biochemistry · Cancer Research · Cell Biology · Internal Medicine
Genomic and GeneChip expression profiling reveals the inhibitory effects of Amorphophalli Rhizoma in TNBC cells
Anti-hepatocellular carcinoma efficacy of Fuzheng Xiaozheng prescription and its interventional mechanism studies
The signaling pathways and targets of traditional Chinese medicine and natural medicine in triple-negative breast cancer
Amorphophalli Rhizoma inhibits breast cancer growth, proliferation, migration, and invasion via the PI3K/AKT pathway
Jianpi Jiedu decoction, a traditional Chinese medicine formula, inhibits tumorigenesis, metastasis, and angiogenesis through the mTOR/HIF-1α/Vegf pathway
| Obras citantes distintas | 5 |
|---|---|
| Citações por ano | 0,63 |
| Intervalo de citações | 2018 - 2022 (5) |
| Velocidade de citação | historical |
| Altamente citado | Não |
| Tipos de citação | Neutras: 5 |